Your browser doesn't support javascript.
loading
Clinicopathological Significance and Prognostic Role of High Mobility Group Box 1 (HMGB1), Toll-Like Receptor (TLR) 2 and TLR4 in Breast Cancer.
Taguchi, Reina; Yamaguchi-Tanaka, Mio; Takagi, Kiyoshi; Sato, Ai; Miki, Yasuhiro; Miyashita, Minoru; Suzuki, Takashi.
Affiliation
  • Taguchi R; Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
  • Yamaguchi-Tanaka M; Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
  • Takagi K; Department of Personalized Medicine Center, Tohoku University Hospital, Sendai, Miyagi 980-8575, Japan.
  • Sato A; Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
  • Miki Y; Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
  • Miyashita M; Department of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
  • Suzuki T; Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8575, Japan.
Acta Histochem Cytochem ; 57(2): 75-83, 2024 Apr 25.
Article in En | MEDLINE | ID: mdl-38695037

Full text: 1 Database: MEDLINE Language: En Journal: Acta Histochem Cytochem Year: 2024 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Language: En Journal: Acta Histochem Cytochem Year: 2024 Type: Article Affiliation country: Japan